{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:23:21Z","timestamp":1772076201645,"version":"3.50.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/mot.0b013e3283094ba3","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T20:44:48Z","timestamp":1236285888000},"page":"400-404","source":"Crossref","is-referenced-by-count":29,"title":["The high-risk donor: viral infections in solid organ transplantation"],"prefix":"10.1097","volume":"13","author":[{"given":"Andrew L","family":"Singer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M","family":"Kucirka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Namuyinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Hanrahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna K","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorry L","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-13-20211004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/clinids\/4.1.35","article-title":"Enzyme immunoassays for the detection of infectious antigens in body fluids: current limitations and future prospects","volume":"4","author":"Yolken","year":"1982","journal-title":"Rev Infect Dis"},{"key":"R4-13-20211004","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1177\/27.8.383822","article-title":"Heterogeneous enzyme immunoassay","volume":"27","author":"O'Beirne","year":"1979","journal-title":"J Histochem Cytochem"},{"issue":"Suppl 2","key":"R5-13-20211004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1423-0410.2000.tb00073.x","article-title":"HIV, HBV and HCV: new developments related to transfusion safety","volume":"78","author":"Busch","year":"2000","journal-title":"Vox Sang"},{"key":"R6-13-20211004","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1111\/j.1600-6143.2007.02012.x","article-title":"The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"key":"R7-13-20211004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1537-2995.1995.35295125745.x","article-title":"Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors","volume":"35","author":"Busch","year":"1995","journal-title":"Transfusion"},{"key":"R8-13-20211004","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"R9-13-20211004","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"R10-13-20211004","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/JCM.40.5.1761-1766.2002","article-title":"Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay","volume":"40","author":"Kolk","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R11-13-20211004","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1046\/j.1537-2995.2003.00424.x","article-title":"Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection","volume":"43","author":"Biswas","year":"2003","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"R12-13-20211004","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S1386-6532(06)80005-3","article-title":"Assessing the impact of HBV NAT on window period reduction and residual risk","volume":"36","author":"Kleinman","year":"2006","journal-title":"J Clin Virol"},{"key":"R13-13-20211004","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tracli.2003.12.003","article-title":"Should HBV DNA NAT replace HBsAg and\/or anti-HBc screening of blood donors?","volume":"11","author":"Busch","year":"2004","journal-title":"Transfus Clin Biol"},{"key":"R14-13-20211004","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00007890-199703270-00010","article-title":"Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement","volume":"63","author":"Bouthot","year":"1997","journal-title":"Transplantation"},{"key":"R15-13-20211004","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1537-2995.2003.00391.x","article-title":"Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening","volume":"43","author":"Kleinman","year":"2003","journal-title":"Transfusion"},{"key":"R16-13-20211004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1246-7820(98)85001-5","article-title":"Prevalence of HIV, HTLV, and hepatitis B and C viruses in blood donors in France, 1992\u20131996","volume":"5","author":"Pillonel","year":"1998","journal-title":"Transfus Clin Biol"},{"key":"R17-13-20211004","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study","volume":"334","author":"Schreiber","year":"1996","journal-title":"N Engl J Med"},{"key":"R18-13-20211004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/clinids\/13.4.537","article-title":"Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review","volume":"13","author":"Erice","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R22-13-20211004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02696657","article-title":"Solid organ transplantation is a reality for patients with HIV infection","volume":"3","author":"Roland","year":"2006","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R25-13-20211004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes","volume":"8","author":"Roland","year":"2008","journal-title":"Am J Transplant"},{"key":"R26-13-20211004","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1600-6143.2006.01546.x","article-title":"Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C","volume":"6","author":"de Vera","year":"2006","journal-title":"Am J Transplant"},{"key":"R27-13-20211004","first-page":"24","article-title":"Liver transplantation in HIV\/hepatitis co-infection","volume":"12","author":"Miro","year":"2007","journal-title":"J HIV Ther"},{"key":"R28-13-20211004","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"47","author":"Duclos-Vallee","year":"2008","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R29-13-20211004","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/00007890-199712270-00027","article-title":"Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease","volume":"64","author":"Madayag","year":"1997","journal-title":"Transplantation"},{"key":"R30-13-20211004","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.transproceed.2005.06.068","article-title":"Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients","volume":"37","author":"Veroux","year":"2005","journal-title":"Transplant Proc"},{"key":"R31-13-20211004","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.transproceed.2006.11.015","article-title":"Living donor liver transplantation from hepatitis B core antibody positive donors","volume":"39","author":"Celebi Kobak","year":"2007","journal-title":"Transplant Proc"},{"key":"R32-13-20211004","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/j.transproceed.2005.10.094","article-title":"The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome","volume":"37","author":"Berber","year":"2005","journal-title":"Transplant Proc"},{"key":"R33-13-20211004","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.transproceed.2004.08.112","article-title":"Heart transplantation using donors positive for hepatitis","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant Proc"},{"key":"R34-13-20211004","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/lt.20449","article-title":"The use of HBsAg-positive organ donors: far more than meets the eye?","volume":"11","author":"Perrillo","year":"2005","journal-title":"Liver Transpl"},{"key":"R35-13-20211004","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1600-6143.2006.01313.x","article-title":"Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor","volume":"6","author":"Yen","year":"2006","journal-title":"Am J Transplant"},{"key":"R36-13-20211004","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2005.01189.x","article-title":"De novo HBV infection caused by an anti-HBc positive donor in a vaccinated liver transplant recipient in spite of anti-HBs response","volume":"6","author":"Moraleda","year":"2006","journal-title":"Am J Transplant"},{"key":"R37-13-20211004","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-0711-5-8","article-title":"Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues","volume":"5","author":"Schreibman","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R38-13-20211004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/lt.500030202","article-title":"The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient","volume":"3","author":"Douglas","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"R39-13-20211004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(94)90934-2","article-title":"\u2018Occult\u2019 hepatitis B virus as source of infection in liver transplant recipients","volume":"343","author":"Chazouilleres","year":"1994","journal-title":"Lancet"},{"key":"R40-13-20211004","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/lt.20471","article-title":"Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection","volume":"11","author":"Franchello","year":"2005","journal-title":"Liver Transpl"},{"key":"R41-13-20211004","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.510270636","article-title":"Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope","volume":"27","author":"Smedile","year":"1998","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R42-13-20211004","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1053-2498(00)00062-0","article-title":"Hepatitis C transmission and infection by orthotopic heart transplantation","volume":"19","author":"Pfau","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"R43-13-20211004","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJM199108153250702","article-title":"Transmission of hepatitis C virus by organ transplantation","volume":"325","author":"Pereira","year":"1991","journal-title":"N Engl J Med"},{"key":"R44-13-20211004","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(05)80148-5","article-title":"Transmission of hepatitis C virus by organ transplantation in the United Kingdom","volume":"20","author":"Wreghitt","year":"1994","journal-title":"J Hepatol"},{"key":"R45-13-20211004","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00007890-199403270-00010","article-title":"Transmission of hepatitis C by kidney transplantation: the risks","volume":"57","author":"Tesi","year":"1994","journal-title":"Transplantation"},{"key":"R46-13-20211004","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/01.ASN.0000034944.90425.75","article-title":"Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation","volume":"13","author":"Bucci","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R47-13-20211004","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","author":"Abbott","year":"2004","journal-title":"Am J Transplant"},{"key":"R48-13-20211004","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(95)90583-9","article-title":"A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group","volume":"345","author":"Pereira","year":"1995","journal-title":"Lancet"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-200808000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:35:09Z","timestamp":1738978509000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-200808000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283094ba3","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}